Clinical trial
Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
NCT00002998 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00002998 |
|---|---|
| Title | Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer |
| Official title | Phase II Study of Gemcitabine (GEMZAR) and Cisplatin (CDDP) in Advanced Breast Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, gemcitabine hydrochloride |
| Enrollment | 59 |
| Start date | Aug 1, 1997 |
| Primary completion | Apr 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Jul 19, 2004 |
| Last update posted | Jul 13, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: